136 results on '"Tien, Feng-Ming"'
Search Results
2. Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
3. Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations
4. Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
5. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
6. Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML
7. Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis
8. Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
9. Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
10. Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
11. Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008–2013
12. Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/Neoplasms
13. Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
14. Clinico-Genetic and Prognostic Analyses of 635 Patients with Myelodysplastic Neoplasms Based on the 2022 World Health Organization Classification
15. P721: VALIDATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES DEFINED BY INTERNATIONAL CONSENSUS CLASSIFICATION
16. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013
17. A case of acute myelomonocytic leukemia morphologically mimicking lymphoblastic leukemia
18. Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia
19. Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies
20. Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification
21. A Special Case of Acute Myelomonocytic Leukemia Morphologically Mimicking Acute Lymphoblastic Leukemia
22. Additional file 1 of Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis
23. Refinement of Myelodysplasia-Related Gene Mutations Listed in the 2022 European LeukemiaNet (ELN-2022) Guidelines Enhances Prognostic Stratification in Acute Myeloid Leukemia
24. AML-765 Refinement of Myelodysplasia-Related Gene Mutations Listed in the 2022 European LeukemiaNet (ELN-2022) Guidelines Enhances Prognostic Stratification in Acute Myeloid Leukemia
25. Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.
26. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
27. Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
28. Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
29. Safety, Feasibility, and Effects of Short-Term Calorie Reduction during Induction Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Pilot Study
30. Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
31. Busulfan‐containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study.
32. Hepatitis B reactivation during treatment of tyrosine kinase inhibitors—Experience in 142 adult patients with chronic myeloid leukemia
33. Polatuzumab Vedotin-Based Salvage Chemotherapy in the Third-Line or Above Treatment for Diffuse Large B-Cell Lymphoma
34. Feasibility, Process, and Effects of Short-Term Calorie Reduction in Cancer Patients Receiving Chemotherapy: An Integrative Review
35. The Clinical Association and Prognostic Impact of IL1RAP Expression in Patients with De Novo Acute Myeloid Leukemia
36. Minimal Residual Disease Monitoring By Next-Generation Sequencing in Patients with Acute Myeloid Leukemia: MRD Positivity after First Consolidation Chemotherapy Can Better Predict Clinical Outcomes Than That after Induction Chemotherapy
37. Automatic Bone Marrow Cell Identification and Classification By Deep Neural Network
38. Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan
39. Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3-ITD Patients
40. Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor inde novoacute myeloid leukemia patients
41. Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
42. Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
43. The Clinical Characteristics, Genetic Alterations and Prognostic Significance of De Novo Acute Myeloid Leukemia (AML) with Hyperleukocytosis (HL)
44. Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008–2013
45. The Clinical and Biological Characterization of De Novo Acute Myeloid Leukemia (AML) with GATA2 Mutation
46. The Clinical Association and Prognostic Impact of IL1RAPExpression in Patients with De NovoAcute Myeloid Leukemia
47. Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novoaml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3-ITD Patients
48. The Clinical Characteristics, Genetic Alterations and Prognostic Significance of De NovoAcute Myeloid Leukemia (AML) with Hyperleukocytosis (HL)
49. The Clinical and Biological Characterization of De NovoAcute Myeloid Leukemia (AML) with GATA2Mutation
50. Hepatitis B reactivation during treatment of tyrosine kinase inhibitors—Experience in 142 adult patients with chronic myeloid leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.